Testagen (Langford Research Institute)
Welcome to the PulseAid listing for the Testagen drug offered from Langford Research Institute. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Langford Research Institute |
| NON-PROPRIETARY NAME: | Testosterone |
| SUBSTANCE NAME: | (1,2,6,7-3H)TESTOSTERONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | TRANSDERMAL |
| DOSAGE FORM: | AEROSOL, SPRAY |
| MARKETING CATEGORY NAME: | IND |
| START MARKETING DATE: | 2016-12-30 |
| END MARKETING DATE: | 0000-00-00 |
Testagen HUMAN PRESCRIPTION DRUG Details:
| Item Description | Testagen from Langford Research Institute |
| LABELER NAME: | Langford Research Institute |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/50mg) |
| START MARKETING DATE: | 2016-12-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70304-001_44e4944f-3e81-5b60-e054-00144ff8d46c |
| PRODUCT NDC: | 70304-001 |
| APPLICATION NUMBER: | IND101271 |
Other (1,2,6,7-3H)TESTOSTERONE Pharmaceutical Manufacturers / Labelers:
